Adenovirus expressing immune cell stimulatory receptor agonist(s)

University of Texas System

Abstract

Certain embodiments include the enhancement of effectiveness for an adenoviral cancer therapy.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Frank Tufaro
Priority date: November 22, 2013
Filing date: October 10, 2024
Publication date: May 29, 2025
Language: en
PDF source: https://patentimages.storage.googleapis.com/f2/19/73/d640d2dba2ba83/US20250171745A1.pdf
Metadata fetched: August 29, 2026 00:32